Innovating Works

FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDI...

Activa
PREVENTABLE: CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DR. JOSEP TRUETA (IDIBGI) participó en un HORIZON EUROPE HORIZON-HLTH-2022-CARE-08 Rare tumour risk syndromes (RTRS) are rare diseases, affecting 5 per 10.000 people or less and caused by heritable genetic variants. In RTRS...
2022-12-02 - 2025-12-31 | Financiado
CGI-Clinics: Data driven cancer genome interpretation for personalised cancer treatment FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DR. JOSEP TRUETA (IDIBGI) participó en un HORIZON EUROPE HORIZON-HLTH-2021-CARE-05 CGI-Clinics aims at improving personalised medicine in oncology by optimizing genomic data interpretation (after sequencing and before advis...
2022-05-20 - 2027-10-31 | Financiado
RBDCOV: RBD Dimer recombinant protein vaccine against SARSCoV2 FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DR. JOSEP TRUETA (IDIBGI) participó en un HORIZON EUROPE HORIZON-HLTH-2021-CORONA-01 The main objective of RBDCOV project is to test the efficacy, tolerability, and safety of a new vaccine against different variants of COVID-...
2021-11-12 - 2024-05-31 | Financiado
SPIOMET4HEALTH: PCOS IN ADOLESCENT GIRLS AND YOUNG WOMEN TOWARD A TREATMENT GUIDED BY PATHOPHYSIOLOGY FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DR. JOSEP TRUETA (IDIBGI) participó en un H2020 H2020-SC1-BHC-2018-2020 Polycystic Ovary Syndrome (PCOS) is the most prevalent, chronic endocrine-metabolic disorder of adolescents and young women (AYAs), affectin...
2021-02-01 - 2026-03-31 | Financiado
SmartAge: Gut brain axis Targets for improvement of cognition in the elderly FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DR. JOSEP TRUETA (IDIBGI) participó en un H2020 H2020-MSCA-ITN-2019 In Europe, the population is aging. The age-associated decline in cognitive functions represents a serious social and medical problem. Recen...
2020-06-22 - 2025-02-28 | Financiado
ProCAncer-I: An AI Platform integrating imaging data and models supporting precision care through prostate cance... FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DR. JOSEP TRUETA (IDIBGI) participó en un H2020 H2020-SC1-FA-DTS-2018-2020 In Europe, prostate cancer (PCa) is the second most frequent type of cancer in men and the third most lethal. Current clinical practices, of...
2020-05-29 - 2024-09-30 | Financiado
SOPHIA: Stratification of Obesity Phenotypes to Optimize Future Therapy FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DR. JOSEP TRUETA (IDIBGI) participó en un H2020 H2020-JTI-IMI2-2019-17-two-stage SOPHIA will optimise the future treatment of obesity. The challenge is that clinicians, payers and patients view obesity as a failure of sel...
2020-05-26 - 2025-05-31 | Financiado
PEPPER: Patient Empowerment through Predictive PERsonalised decision support FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DR. JOSEP TRUETA (IDIBGI) participó en un H2020 H2020-PHC-2014-2015 This proposal is for a personalised decision support system for chronic disease management that will make predictions based on real-time dat...
2015-11-10 - 2020-03-31 | Financiado
RESSTORE: REgenerative Stem cell therapy for STroke in Europe FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DR. JOSEP TRUETA (IDIBGI) participó en un H2020 H2020-PHC-2014-2015 Stroke is the second leading cause of death in the world population. When not fatal, stroke often results in disability, due to motor and co...
2015-09-15 - 2020-08-31 | Financiado
WAKE-UP: Efficacy and safety of MRI based thrombolysis in wake up stroke a randomised double blind placebo... FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DR. JOSEP TRUETA (IDIBGI) participó en un FP7 WAKE-UP is an investigator-initiated, multicentre, randomised, double-blind, placebo-controlled trial designed to test efficacy and safety o...
Financiado
FLORINASH: The role of intestinal microflora in non alcoholic fatty liver disease NAFLD FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DR. JOSEP TRUETA (IDIBGI) participó en un FP7 As worldwide metabolic disease pandemics rise relentlessly with their concomitant clinical complications such as non alcoholic fatty liver d...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.